Related references
Note: Only part of the references are listed.Temporal trends in prevalence and outcomes of atrial fibrillation in patients undergoing percutaneous coronary intervention
Yusuke Morita et al.
CLINICAL CARDIOLOGY (2020)
2018 ESC/EACTS Guidelines on myocardial revascularization
Franz-Josef Neumann et al.
EUROPEAN HEART JOURNAL (2019)
ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management JACC Guideline Comparison
Maninder Singh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Dirk Sibbing et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2019)
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI JACC State-of-the-Art Review
Davide Capodanno et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
REPLY: Platelet Function and Genetic Testing in Patients Receiving Oral Anticoagulation and Antiplatelet Treatment
Dirk Sibbing et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2019)
Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy Results From a Nationwide Danish Cohort Study
Nienke van Rein et al.
CIRCULATION (2019)
Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort study
Chaoyue Hu et al.
BMC CARDIOVASCULAR DISORDERS (2018)
Platelet function testing: dead or alive
C. Helten et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding
Wayne A. Ray et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal
James Demetrios Douketis
INTERNAL AND EMERGENCY MEDICINE (2016)
Relationship between pharmacokinetics and pharmacodynamics of clopidogrel in patients undergoing percutaneous coronary intervention: comparison between vasodilator-stimulated phosphoprotein phosphorylation assay and multiple electrode aggregometry
E. Danese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
Daniel Aradi et al.
EUROPEAN HEART JOURNAL (2015)
The Prognostic Value of Bleeding Academic Research Consortium (BARC)-Defined Bleeding Complications in ST-Segment Elevation Myocardial Infarction A Comparison With the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) Bleeding Classifications
Wouter J. Kikkert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Importance of Pharmacokinetic Profile and Variability as Determinants of Dose and Response to Dabigatran, Rivaroxaban, and Apixaban
Inna Y. Gong et al.
CANADIAN JOURNAL OF CARDIOLOGY (2013)
Rivaroxaban and risk of myocardial infarction: insights from a meta- analysis and trial sequential analysis of randomized clinical trials
Saurav Chatterjee et al.
CORONARY ARTERY DISEASE (2013)
Apixaban in patients with atrial fibrillation and prior coronary artery disease: Insights from the ARISTOTLE trial
Maria Cecilia Bahit et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding
Udaya S. Tantry et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention
Morten Lamberts et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients
Pascal Vranckx et al.
EUROINTERVENTION (2013)
Relationship between post-treatment platelet reactivity and ischemic and bleeding events at 1-year follow-up in patients receiving prasugrel
L. Bonello et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator A Systematic Review and Meta-Analysis of 55 Studies
William N. Whiteley et al.
STROKE (2012)
Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis
Daniel Aradi et al.
AMERICAN HEART JOURNAL (2010)
Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel
Dirk Sibbing et al.
EUROPEAN HEART JOURNAL (2010)
Platelet Aggregation and Its Association With Stent Thrombosis and Bleeding in Clopidogrel-Treated Patients Initial Evidence of a Therapeutic Window
Dirk Sibbing et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.
Tabassome Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Impact of P-glycoprotein on clopidogrel absorption
Dirk Taubert et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Share Paper
